Pelage Pharmaceuticals
Pelage Pharmaceuticals is a clinical-stage biotechnology company developing regenerative medicines for hair loss based on hair follicle stem cell biology discovered by UCLA researchers. Its lead candidate, PP405, is a topically-applied small molecule that reactivates dormant hair follicle stem cells via a metabolic switch to stimulate regrowth, targeting androgenetic alopecia, drug-induced alopecia, and telogen effluvium; it is non-hormonal, non-invasive, and in Phase 2 clinical trials. The company was surfaced as a portfolio company of GV (Google Ventures). It publishes a corporate site and a clinical-trials site but no public developer, API, or technical surface.
Pelage Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Pharmaceuticals, Biotechnology, and Regenerative Medicine.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API